| Dr Charles Timothy Via, MD | |
|
1906 Belleview Ave Se, Roanoke, VA 24014-1838 | |
| (540) 981-7273 | |
| Not Available |
| Full Name | Dr Charles Timothy Via |
|---|---|
| Gender | Male |
| Speciality | Pathology - Anatomic Pathology & Clinical Pathology |
| Location | 1906 Belleview Ave Se, Roanoke, Virginia |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1720087794 | NPI | - | NPPES |
| 0102731000 | Medicaid | WV | |
| 220030569 | Other | RAILROAD MEDICARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207ZP0102X | Pathology - Anatomic Pathology & Clinical Pathology | 0101035985 (Virginia) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Charles Timothy Via, MD Po Box 21569, Roanoke, VA 24018-0568 Ph: () - | Dr Charles Timothy Via, MD 1906 Belleview Ave Se, Roanoke, VA 24014-1838 Ph: (540) 981-7273 |
News Archive
Increasing highly active antiretroviral therapy treatment for people with HIV/AIDS will provide significant cost savings over a relatively short period of time, according to a formal economic analysis led by researchers at the BC Centre for Excellence in HIV/AIDS (BC-CfE) at Providence Health Care and the University of British Columbia.
Merck, known as MSD outside the United States and Canada, (NYSE: MRK) and Endocyte, Inc. (NASDAQ: ECYT) today announced the online publication of results from the randomized Phase II PRECEDENT trial for vintafolide (MK-8109/EC145), an investigational folate small molecule drug conjugate (SMDC), in the Journal of Clinical Oncology (JCO), the official journal of the American Society of Clinical Oncology.
Where people die can affect the quality of their deaths and the end-of-life care that they receive. A study published in the Journal of the American Geriatrics Society found that satisfaction with end-of-life care was rated highest when individuals died at home.
Boehringer Ingelheim and Eli Lilly and Company today presented the full results of the long-term cardiovascular outcome trial, CARMELINA®, which studied the impact of Trajenta® (linagliptin) on cardiovascular and kidney safety in adults with type 2 diabetes at high risk for heart and/or kidney disease.
› Verified 6 days ago
Dr. Alden W Dudley Jr., MD Pathology Medicare: Not Enrolled in Medicare Practice Location: 5909 Winnbrook Dr, Roanoke, VA 24018 Phone: 540-772-6929 Fax: 540-772-6929 | |
Dr. Robert Earl Pooley, M.D. Pathology Medicare: Not Enrolled in Medicare Practice Location: 5129 Red Stag Rd, Roanoke, VA 24018 Phone: 540-774-7835 | |
Dr. Brian Keith Newman, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 1 Riverside Cir Ste 105, Roanoke, VA 24016 Phone: 540-581-0155 | |
Dr. Douglas James Grider, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 1906 Belleview Ave Se, Roanoke, VA 24014 Phone: 540-981-7271 | |
Dr. Pragna Dhimant Sheth, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 1906 Belleview Ave Se, Roanoke, VA 24014 Phone: 540-981-7273 | |
Dr. Amy M. Tharp, MD Pathology Medicare: Not Enrolled in Medicare Practice Location: 6600 Northside High School Rd., Roanoke, VA 24019 Phone: 540-561-6615 Fax: 540-561-6619 | |
Dr. William Emmett Jefferson Iii, MD Pathology Medicare: Not Enrolled in Medicare Practice Location: 1 Riverside Cir, Suite 105, Roanoke, VA 24016 Phone: 540-581-0150 |